by Richard Daverman, PhD
November 26, 2012 -- According to reports, a 24% stake in China Pharmaceutical R&D Center Co. is up for sale at a price of 15.4 million RMB ($2.5 million). The company is an R&D, technology and service platform under the state-owned China Resources Pharmaceutical Group Limited. The company reported declining revenues and a net loss for the first nine months of 2012. More details....
